Expertise in
16
conditions

Dr. Vivek Nagaraja

Geriatrics
Office
1500 E Medical Center Dr Spc 5370, 
Ann Arbor, MI 
Offers Telehealth
Expertise in
16
conditions
Office
1500 E Medical Center Dr Spc 5370, 
Ann Arbor, MI 

Overview

Vivek Nagaraja is a Geriatrics provider in Ann Arbor, Michigan. Dr. Nagaraja is highly rated in 16 conditions, according to our data. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema.

His clinical research consists of co-authoring 36 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Geriatrics

Licenses

Internal Medicine in MI

Hospital Affiliations

Mayo Clinic Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Office
1500 E Medical Center Dr Spc 5370, Ann Arbor, MI 48109
Other Locations
Mayo Clinic Building Scottsdale
13400 E Shea Blvd, Scottsdale, AZ 85259

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: December 15, 2023
Intervention Type: Drug
Study Drugs: Pirfenidone, Mycophenolate Mofetil
Study Phase: Phase 2
A Multi-Center Cluster Randomized Controlled Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
A Multi-Center Cluster Randomized Controlled Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 6 Less Clinical Trials

36 Total Publications

The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis.
The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective Analysis.
Journal: Journal of clinical medicine
Published: April 28, 2025
Similar Doctors
Expertise in
3
conditions
Dr. Lona Mody
Geriatrics
Expertise in
3
conditions
Dr. Lona Mody
Geriatrics

Regents Of The Univ. Of Michigan

4260 Plymouth Rd, 
Ann Arbor, MI 
 (1637.1 miles away)
734-764-6831
Languages Spoken:
English
See accepted insurances

Lona Mody is a primary care provider, practicing in Geriatrics in Ann Arbor, Michigan. Dr. Mody is highly rated in 3 conditions, according to our data. Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Urinary Tract Infection (UTI), Asymptomatic Bacteriuria, Severe Acute Respiratory Syndrome (SARS), and Hormone Replacement Therapy (HRT).

Martha Gray
Expertise in
16
conditions
Dr. Martha Gray
Geriatrics
Expertise in
16
conditions
Dr. Martha Gray
Geriatrics

Partners In Internal Medicine PLLC

2200 Green Rd Ste B, 
Ann Arbor, MI 
 (1636.3 miles away)
734-994-7446
Languages Spoken:
English
See accepted insurances

Martha Gray is a primary care provider, practicing in Geriatrics in Ann Arbor, Michigan. Dr. Gray is highly rated in 16 conditions, according to our data. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Breast Cancer.

Expertise in
12
conditions
Dr. Ronak Talati
Geriatrics
Expertise in
12
conditions
Dr. Ronak Talati
Geriatrics

Office

43134 Dequindre Rd, 
Sterling Heights, MI 
 (1670.6 miles away)
586-446-8688
Languages Spoken:
English
See accepted insurances

Ronak Talati is a Geriatrics provider in Sterling Heights, Michigan. Dr. Talati is highly rated in 12 conditions, according to our data. His top areas of expertise are Osteomyelitis, Lymphangitis, Sepsis, and Osteomyelitis in Children.

Frequently Asked Questions about Dr. Vivek Nagaraja

How do I make an appointment with Dr. Vivek Nagaraja?

You can book an appointment with Dr. Vivek Nagaraja by calling their office at 734-647-5900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Vivek Nagaraja a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vivek Nagaraja is classified as an Elite expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Vivek Nagaraja specialize in?

While Dr. Vivek Nagaraja is a Geriatrics, they have specific expertise in Scleroderma, Systemic Sclerosis (SSc), and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Geriatrics.

Does Dr. Vivek Nagaraja participate in research or clinical trials?

Yes. Dr. Vivek Nagaraja has published 36 articles and abstracts on conditions like Scleroderma. You can view a list of Dr. Vivek Nagaraja's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Vivek Nagaraja accept my insurance?

Dr. Vivek Nagaraja accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-5900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nagaraja's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile